Fortress Biotech Announces Closing of $10.0 Million Public Offering

Stock Information for Fortress Biotech Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Fortress Biotech Inc.

Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics
Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
Checkpoint Therapeutics Reports First Quarter Financial Results and Recent Corporate Updates
Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025
Fortress Biotech to Participate in the H.C. Wainwright 1st Annual Royalty Company Virtual Conference
Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer
Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.